Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer (NeoFox)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03883802

Recruitment Status : Active, not recruiting

First Posted : March 21, 2019

Last Update Posted : December 9, 2022

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

SMS-Oncology BV

SAGA diagnostics AB

Unilabs A/S

BioVica AB

Institut Català d'Oncologia

Information provided by (Responsible Party):

WntResearch AB

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	December 14, 2024
Estimated Study Completion Date :	December 14, 2024

To Top